ONCTERNAL THERAPEUTICS INC - COM (ONCT)

CUSIP: 68236P107

Q1 2022 13F Holders as of 31 Mar 2022

Type / Class
Equity / COM
Total 13F shares
13,387,352
Share change
-17,347
Total reported value
$18,626,136
Put/Call ratio
365%
Price per share
$1.39
Number of holders
75
Value change
-$589,229
Number of buys
33
Number of sells
43

Quarterly Holders Quick Answers

What is CUSIP 68236P107?
CUSIP 68236P107 identifies ONCT - ONCTERNAL THERAPEUTICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of ONCTERNAL THERAPEUTICS INC - COM (ONCT) as of Q1 2022

As of 31 Mar 2022, ONCTERNAL THERAPEUTICS INC - COM (ONCT) was held by 75 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 13,387,352 shares. The largest 10 holders included BlackRock Inc., VANGUARD GROUP INC, STATE STREET CORP, GEODE CAPITAL MANAGEMENT, LLC, RENAISSANCE TECHNOLOGIES LLC, MORGAN STANLEY, MILLENNIUM MANAGEMENT LLC, Quantum Private Wealth, LLC, HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND, and NORTHERN TRUST CORP. This page lists 75 institutional shareholders reporting positions in this security for the Q1 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.